Recommended Products

The FDAnews report EU MDR Compliance can help. Our editors have combed through the regulations, picking out the most minute compliance points and building them into a checklist of 200+ requirements you can use to confirm that you are satisfying all the EU mandates for device manufacturing.

FDA Clears Phase 1 Trial of IND for Bone Marrow Failure Syndrome

Cellenkos received FDA clearance for a Phase I clinical trial of its investigational new drug CK0801 intended to treat bone marrow failure syndrome including aplastic anemia, myelodysplastic syndrome and myelofibrosis.

CK0801 is described as an ‘off-the-shelf’ cord blood derived regulatory T cell product used for treating immune dysfunction by obstructing regulators of inflammation.

The trial will begin in the third quarter of 2018 at the University of Texas’ MD Anderson Cancer Center.